Monthly Prescribing Reference

Breo Ellipta

Fluticasone furoate, vilanterol 50/25mcg, 100/25mcg, 200/25mcg; per inh; dry pwd for oral inh. Fluticasone furoate is a synthetic trifluorinated corticosteroid with anti-inflammatory activity. The ...
Healthline

Trelegy Ellipta Interactions: Alcohol, Medications, and Others

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) is a prescription inhaler used to treat asthma or COPD in adults. This drug can interact with certain ...
Healthline

Trelegy Ellipta: How It’s Used for Treating COPD

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) is a prescription drug used to treat COPD. With COPD, you have lung damage that worsens over time ...
RAPS

GSK's new COPD Therapy Wins FDA Approval

The US Food and Drug Administration (FDA) has approved GlaxoSmithKline's chronic obstructive pulmonary disorder (COPD) drug Breo Ellipta (fluticasone furoate and vilanterol inhalation powder), just ...
Reuters

GSK, Theravance submit sNDA to U.S. FDA for Breo Ellipta

* Today's filing is based upon data generated from comprehensive clinical development programme for FF/VI in asthma * sNDA is seeking approval for two dose regimens, 100/25mcg and 200/25mcg, ...